Reported record total revenue of $19.2 million in the fourth quarter of 2025Scaling U.S. commercial launch of AYON Body Contouring System™ (AYON) ...
A Nasdaq-listed biotechnology company repositioned as a global platform for acquiring and advancing clinical-stage assets. NovaBridge Biosciences is built around two principal programs, givastomig in ...
Great. Good morning, everybody. I'm Luke Sergott, I cover Life Science Tools Diagnostics here for Barclays. With me, I have Eric Green, CEO; and Bob McMahon, CFO; and we have John Sweeney over there ...
Earnings call Priority Technology Holdings reported Q4 revenue up 9% YoY to $247.1M and full-year revenue up 8%, with adjusted EBITDA rising 16% in Q4 and 10% for FY25. Management guided for 6%-9% top ...
Leerink Global Healthcare Conference 2026 March 10, 2026 11:20 AM EDTCompany ParticipantsDietmar Berger - Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results